Lonza to create 1,200 new jobs at vaccine-production site
Lonza said it was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and the United Kingdom.
Keystone / Alessandro Della Valle
The Swiss pharmaceutical company is recruiting workers to join its new plant in southern Switzerland, where three production lines have been set up to manufacture an active ingredient of Moderna’s Covid-19 vaccine.
This content was published on
1 minute
Keystone-SDA/gw
So far the firm has hired 650 new staff to work at its Visp site in canton Valais, said site director Renzo Cicillini in a media interview published on Saturday.
Cicillini added that Lonza was recruiting from the Swiss labour market as well as from countries such as Germany, France, northern Italy and Britain.
The multinational signed a ten-year contract with American firm Moderna in 2020 to supply ingredients for up to one billion doses of its Covid vaccine a year for the global market, excluding the United States. Only in January, Lonza had projected the need for 200 workers in Visp to meet a yearly target of 300 million doses.
Asked whether the Swiss government would support a vaccine production line in Visp, Cicillini said the company’s CEO, Albert Baehny, was in contact with the health minister, Alain Berset, and that the media would be informed of any new development.
Recent media reports claimed that Berset turned down an opportunity last year to secure a vaccine production line exclusively for Switzerland by investing in Lonza, reports that Berset has rejected.
Popular Stories
More
Life & Aging
Switzerland no longer wants to foot the bill for ‘suicide tourism’
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss sign human rights declaration for Women’s Euro 2025
This content was published on
Sports Minister Viola Amherd has signed a human rights declaration for the 2025 European Women's Football Championship in Switzerland.
Swiss parliament wants to expand support for asbestos victims
This content was published on
The expansion of financial support for asbestos victims by the Swiss National Accident Insurance Fund has cleared its first parliamentary hurdle.
Extra month of Swiss pension can be paid out from end of 2026
This content was published on
The 13th monthly pension payment can be paid out from December 2026. However, it has not yet been decided how it will be financed.
Addictions cause billions in damage in Switzerland
This content was published on
The alcohol, tobacco and gambling industries generate billions in revenue. At the same time, they cost the economy billions, according to Addiction Switzerland.
Swiss parliament moves closer to partial ban of tobacco ads
This content was published on
Tobacco advertising should be partially banned in the print media. On Monday the House of Representatives gave the go-ahead for restrictions on advertising, with some relaxations.
Online platforms and UBS in sights of Swiss price watchdog
This content was published on
With over 800 cases processed, including just under 400 recommendations, 2024 once again ended with a record number of cases for the Swiss price watchdog.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
New Lonza site can now make Covid-19 vaccine ingredient
This content was published on
Swissmedic, the Swiss Agency for Therapeutic Products, has approved Lonza’s new site for making Moderna’s Covid-19 active substance.
This content was published on
The Swiss health authorities say they plan to roll out a certificate for people who have been vaccinated against coronavirus by summer.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.